{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T04:12:38Z","timestamp":1748751158279,"version":"3.41.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-03031-6","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T06:27:30Z","timestamp":1748327250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of bone status and bone turnover in pediatric patients with familiar hypomagnesemia with hypercalciuria and nephrocalcinosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Beata","family":"Bienia\u015b","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Wieczorkiewicz-P\u0142aza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Zaniew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Pulcer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Szczepa\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Moczulska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Rogowska-Kalisz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Tkaczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danuta","family":"Ostalska-Nowicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Zachwieja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Zawadzki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Konrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Przemys\u0142aw","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"issue":"10","key":"3031_CR1","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1007\/s00467-021-04968-2","volume":"36","author":"M Vall-Palomar","year":"2021","unstructured":"Vall-Palomar, M., Madariaga, L. & Ariceta, G. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Pediatr. Nephrol. 36 (10), 3045\u20133055 (2021).","journal-title":"Pediatr. Nephrol."},{"issue":"5","key":"3031_CR2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/MNH.0b013e32833b7125","volume":"19","author":"J Hou","year":"2010","unstructured":"Hou, J. & Goodenough, D. A. Claudin-16 and claudin-19 function in the Thick ascending limb. Curr. Opin. Nephrol. Hypertens. 19 (5), 483\u2013488 (2010).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"3031_CR3","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/ki.1995.199","volume":"47","author":"M Praga","year":"1995","unstructured":"Praga, M. et al. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int. 47, 1419\u20131425 (1995).","journal-title":"Kidney Int."},{"key":"3031_CR4","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2215\/CJN.12841211","volume":"7","author":"A Godron","year":"2012","unstructured":"Godron, A. et al. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutations. Clin. J. Am. Soc. Nephrol. 7, 801\u2013809 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"3031_CR5","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s00467-002-0884-4","volume":"17","author":"MT Wolf","year":"2002","unstructured":"Wolf, M. T., D\u00f6tsch, J., Konrad, M., B\u00f6swald, M. & Rascher, W. Follow-up of five patients with FHHNC due to mutations in the Paracellin-1 gene. Pediatr. Nephrol. 17, 602\u2013608 (2002).","journal-title":"Pediatr. Nephrol."},{"key":"3031_CR6","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/ndt\/gfu374","volume":"30","author":"P Sikora","year":"2015","unstructured":"Sikora, P. et al. Retrospective cohort study of Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis due to CLDN16 mutations. Nephrol. Dial Transpl. 30, 636\u2013644 (2015).","journal-title":"Nephrol. Dial Transpl."},{"key":"3031_CR7","first-page":"372","volume-title":"Ultraschalldiagnostik in P\u00e4diatrie Und Kinderchirurgie","author":"PF Hoyer","year":"1996","unstructured":"Hoyer, P. F. Nephrocalcinose. In (eds Hofmann, V., Deeg, K. H. & Hoyer, P. F.) Ultraschalldiagnostik in P\u00e4diatrie Und Kinderchirurgie. Thieme, Stuttgart. : 372\u2013374. (1996)."},{"issue":"2","key":"3031_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jocd.2014.01.003","volume":"17","author":"NJ Crabtree","year":"2014","unstructured":"Crabtree, N. J. et al. Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD pediatric official positions. J. Clin. Densitom. 17 (2), 225\u2013242 (2014).","journal-title":"J. Clin. Densitom"},{"key":"3031_CR9","doi-asserted-by":"crossref","unstructured":"Shuhart, C.R. et al. Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics. J. Clin. Densitom. 22, 453\u2013471 (2019).","DOI":"10.1016\/j.jocd.2019.07.001"},{"key":"3031_CR10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz, G. J. et al. New equations to estimate GFR in children with CKD. J. Am. Soc. Nephrol. 20, 629\u2013637 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3031_CR11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/sj.ejhg.5200475","volume":"8","author":"S Weber","year":"2000","unstructured":"Weber, S. et al. Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis maps to chromosome 3q27 and is associated with mutations in the PLCN-1 gene. Eur. J. Hum. Genet. 8, 414\u2013422 (2000).","journal-title":"Eur. J. Hum. Genet."},{"issue":"4","key":"3031_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1442-2042.2005.01049.x","volume":"12","author":"H Tsuji","year":"2005","unstructured":"Tsuji, H. et al. Analysis of bone mineral density in urolithiasis patients. Int. J. Urol. 12 (4), 335\u2013339 (2005).","journal-title":"Int. J. Urol."},{"issue":"2","key":"3031_CR13","first-page":"118","volume":"5","author":"S Sella","year":"2008","unstructured":"Sella, S., Cattelan, C., Realdi, G. & Giannini, S. Bone disease in primary hypercalciuria. Clin. Cases Min. Bone Metab. 5 (2), 118\u2013126 (2008).","journal-title":"Clin. Cases Min. Bone Metab."},{"issue":"4","key":"3031_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ki.2010.473","volume":"79","author":"K Sakhaee","year":"2011","unstructured":"Sakhaee, K., Maalouf, N. M., Kumar, R., Pasch, A. & Moe, O. W. Nephrolithiasis associated bone disease: pathogenesis and treatment options. Kidney Int. 79 (4), 393\u2013403 (2011).","journal-title":"Kidney Int."},{"issue":"5","key":"3031_CR15","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s004670050341","volume":"11","author":"V Garc\u00eda-Nieto","year":"1997","unstructured":"Garc\u00eda-Nieto, V., Ferr\u00e1ndez, C., Monge, M., De Sequera, M. & Rodrigo, M. D. Bone mineral density in pediatric patients with idiopathic hypercalciuria. Pediatr. Nephrol. 11 (5), 578\u2013583 (1997).","journal-title":"Pediatr. Nephrol."},{"issue":"8","key":"3031_CR16","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1093\/ndt\/17.8.1396","volume":"17","author":"M Freundlich","year":"2002","unstructured":"Freundlich, M., Alonzo, E., Bellorin-Font, E. & Weisinger, J. R. Reduced bone mass in children with idiopathic hypercalciuria and in their asymptomatic mothers. Nephrol. Dial Transpl. 17 (8), 1396\u20131401 (2002).","journal-title":"Nephrol. Dial Transpl."},{"issue":"3","key":"3031_CR17","first-page":"356","volume":"19","author":"I Artemiuk","year":"2015","unstructured":"Artemiuk, I., Pa\u0144czyk-Tomaszewska, M., Adamczuk, D., Przedlacki, J. & Roszkowska-Blaim, M. Bone mineral density in children with idiopathic hypercalciuria. Dev. Period Med. 19 (3), 356\u2013361 (2015).","journal-title":"Dev. Period Med."},{"issue":"2","key":"3031_CR18","first-page":"260","volume":"16","author":"R Caudarella","year":"2003","unstructured":"Caudarella, R. et al. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. J. Nephrol. 16 (2), 260\u2013266 (2003).","journal-title":"J. Nephrol."},{"issue":"6","key":"3031_CR19","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.juro.2017.01.002","volume":"197","author":"K Sakhaee","year":"2017","unstructured":"Sakhaee, K., Maalouf, N. M., Poindexter, J., Adams-Huet, B. & Moe, W. Relationship between urinary calcium and bone mineral density in patients with calcium nephrolithiasis. J. Urol. 197 (6), 1472\u20131477 (2017).","journal-title":"J. Urol."},{"issue":"6","key":"3031_CR20","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/MOU.0000000000000111","volume":"24","author":"MA Arrabal-Polo","year":"2014","unstructured":"Arrabal-Polo, M. A., Cano-Garc\u00eda, M. C., Canales, B. K. & Arrabal-Mart\u00edn, M. Calcium nephrolithiasis and bone demineralization: pathophysiology, diagnosis, and medical management. Curr. Opin. Urol. 24 (6), 633\u2013638 (2014).","journal-title":"Curr. Opin. Urol."},{"issue":"21","key":"3031_CR21","doi-asserted-by":"publisher","first-page":"8183","DOI":"10.3390\/ijms21218183","volume":"21","author":"D Rendina","year":"2020","unstructured":"Rendina, D. et al. Idiopathic osteoporosis and nephrolithiasis: two sides of the same coin? Int. J. Mol. Sci. 21 (21), 8183 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"3031_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1681\/ASN.2007060709","volume":"19","author":"M Konrad","year":"2008","unstructured":"Konrad, M. et al. CLDN16 genotype predicts renal decline in Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J. Am. Soc. Nephrol. 19, 171\u2013181 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"3031_CR23","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/ndt\/gft400","volume":"29","author":"ME Rodr\u00edguez-Ortiz","year":"2014","unstructured":"Rodr\u00edguez-Ortiz, M. E. et al. Magnesium modulates parathyroid hormone secretion and upregulates parathyroid receptor expression at moderately low calcium concentration. Nephrol. Dial Transpl. 29 (2), 282\u2013289 (2014).","journal-title":"Nephrol. Dial Transpl."},{"issue":"Suppl 4","key":"3031_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/ndt\/gfu198","volume":"29","author":"M Konrad","year":"2014","unstructured":"Konrad, M. & Schlingmann, K. P. Inherited disorders of renal hypomagnesaemia. Nephrol. Dial Transpl. 29 (Suppl 4), 63\u201371 (2014).","journal-title":"Nephrol. Dial Transpl."},{"key":"3031_CR25","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s00431-013-1979-6","volume":"172","author":"P Sikora","year":"2013","unstructured":"Sikora, P. et al. Bilateral slipped capital femoral epiphysis in a male adolescent with Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC), chronic renal failure, and severe hyperparathyroidism. Eur. J. Pediatr. 172, 1551\u20131555 (2013).","journal-title":"Eur. J. Pediatr."},{"issue":"5\u20136","key":"3031_CR26","first-page":"713","volume":"28","author":"EA Cimbek","year":"2015","unstructured":"Cimbek, E. A., \u015een, Y., Yuca, S. A. & Peru, H. Chondrocalcinosis related to Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J. Pediatr. Endocrinol. Metab. 28 (5\u20136), 713\u2013716 (2015).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"8","key":"3031_CR27","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3389\/fphys.2017.00326","volume":"24","author":"C Bardet","year":"2017","unstructured":"Bardet, C. et al. Claudin Loss-of-Function disrupts tight junctions and impairs amelogenesis. Front. Physiol. 24 (8), 326 (2017).","journal-title":"Front. Physiol."},{"issue":"12","key":"3031_CR28","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jnutbio.2004.08.001","volume":"15","author":"RK Rude","year":"2004","unstructured":"Rude, R. K. & Gruber, H. E. Magnesium deficiency and osteoporosis: animal and human observations. J. Nutr. Biochem. 15 (12), 710\u2013716 (2004).","journal-title":"J. Nutr. Biochem."},{"issue":"6","key":"3031_CR29","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/ajcn\/65.6.1831","volume":"65","author":"SA New","year":"1997","unstructured":"New, S. A., Bolton-Smith, C., Grubb, D. A. & Reid, D. M. Nutritional influences on bone mineral density: a cross-sectional study in premenopausal women. Am. J. Clin. Nutr. 65 (6), 1831\u20131839 (1997).","journal-title":"Am. J. Clin. Nutr."},{"issue":"7","key":"3031_CR30","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s00198-016-3515-9","volume":"27","author":"LM Ward","year":"2016","unstructured":"Ward, L. M., Konji, V. N. & Ma, J. The management of osteoporosis in children. Osteoporos. Int. 27 (7), 2147\u20132179 (2016).","journal-title":"Osteoporos. Int."},{"issue":"2","key":"3031_CR31","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1373\/clinchem.2016.259085","volume":"63","author":"MB Greenblatt","year":"2017","unstructured":"Greenblatt, M. B., Tsai, J. N. & Wein, M. N. Bone turnover markers in the diagnosis and monitoring of metabolic bone disease. Clin. Chem. 63 (2), 464\u2013474 (2017).","journal-title":"Clin. Chem."},{"key":"3031_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bone.2018.06.011","volume":"114","author":"MC Vlot","year":"2018","unstructured":"Vlot, M. C. et al. Clinical utility of bone markers in various diseases. Bone 114, 215\u2013225 (2018).","journal-title":"Bone"},{"issue":"5","key":"3031_CR33","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1359\/jbmr.2003.18.5.859","volume":"18","author":"P Garnero","year":"2003","unstructured":"Garnero, P. et al. The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J. Bone Min. Res. 18 (5), 859\u2013867 (2003).","journal-title":"J. Bone Min. Res."},{"issue":"Pt 2","key":"3031_CR34","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/0004563213515190","volume":"51","author":"TT Hlaing","year":"2014","unstructured":"Hlaing, T. T. & Compston, J. E. Biochemical markers of bone turnover - uses and limitations. Ann. Clin. Biochem. 51 (Pt 2), 189\u2013202 (2014).","journal-title":"Ann. Clin. Biochem."},{"issue":"5","key":"3031_CR35","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.beem.2018.05.003","volume":"32","author":"P Szulc","year":"2018","unstructured":"Szulc, P. Bone turnover: biology and assessment tools. Best Pract. Res. Clin. Endocrinol. Metab. 32 (5), 725\u2013738 (2018).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"1","key":"3031_CR36","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/os.12596","volume":"12","author":"XL Qu","year":"2020","unstructured":"Qu, X. L. et al. Bone turnover markers and bone mineral density to predict osteoporotic fractures in older women: A retrospective comparative study. Orthop. Surg. 12 (1), 116\u2013123 (2020).","journal-title":"Orthop. Surg."},{"issue":"6","key":"3031_CR37","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/os.12567","volume":"11","author":"YN Chen","year":"2019","unstructured":"Chen, Y. N., Wei, P. & Bs, J. Y. Higher concentration of serum C-terminal cross-linking telopeptide of type I collagen is positively related with inflammatory factors in postmenopausal women with H-type hypertension and osteoporosis. Orthop. Surg. 11 (6), 1135\u20131141 (2019).","journal-title":"Orthop. Surg."},{"issue":"4","key":"3031_CR38","doi-asserted-by":"publisher","first-page":"e23112","DOI":"10.1002\/jcla.23112","volume":"34","author":"C Zhao","year":"2020","unstructured":"Zhao, C. et al. Association between serum levels of bone turnover markers and bone mineral density in men and women with type 2 diabetes mellitus. J. Clin. Lab. Anal. 34 (4), e23112 (2020).","journal-title":"J. Clin. Lab. Anal."},{"issue":"12","key":"3031_CR39","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1007\/s00198-014-2808-0","volume":"25","author":"R Sapir-Koren","year":"2014","unstructured":"Sapir-Koren, R. & Livshits, G. Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles? Osteoporos. Int. 25 (12), 2685\u20132700 (2014).","journal-title":"Osteoporos. Int."},{"issue":"20","key":"3031_CR40","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1007\/s00018-008-8177-0","volume":"65","author":"Y Nabeshima","year":"2008","unstructured":"Nabeshima, Y. The discovery of alpha-Klotho and FGF23 unveiled new insight into calcium and phosphate homeostasis. Cell. Mol. Life Sci. 65 (20), 3218\u20133230 (2008).","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"3031_CR41","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.bbrc.2012.12.056","volume":"18","author":"L Hu","year":"2013","unstructured":"Hu, L., Andersson, G., Jonsson, K. B., Melhus, H. & Lind, T. Adamts1 is highly induced in rachitic bones of FGF23 Transgenic mice and participates in degradation of non-mineralized bone matrix collagen. Biochem. Biophys. Res. Commun. 18 (3), 901\u2013906 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"3031_CR42","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00223-011-9501-5","volume":"89","author":"V Shalhoub","year":"2011","unstructured":"Shalhoub, V. et al. Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization. Calcif Tissue Int. 89 (2), 140\u2013150 (2011).","journal-title":"Calcif Tissue Int."},{"key":"3031_CR43","doi-asserted-by":"crossref","unstructured":"Mattinzoli, D. et al. FGF23-regulated production of Fetuin-A (AHSG) in osteocytes. Bone 83, 35\u201347  (2016) (erratum in: Bone 2016; 93:236).","DOI":"10.1016\/j.bone.2016.03.008"},{"issue":"4","key":"3031_CR44","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3390\/ijms20040915","volume":"20","author":"D Mattinzoli","year":"2019","unstructured":"Mattinzoli, D. et al. FGF23 and Fetuin-A interaction and mesenchymal osteogenic transformation. Int. J. Mol. Sci. 20 (4), 915 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"3031_CR45","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1177\/0192623317737469","volume":"45","author":"RG Erben","year":"2017","unstructured":"Erben, R. G. Pleiotropic actions of FGF23. Toxicol. Pathol. 45 (7), 904\u2013910 (2017).","journal-title":"Toxicol. Pathol."},{"issue":"9(1","key":"3031_CR46","doi-asserted-by":"publisher","first-page":"14989","DOI":"10.1038\/s41598-019-51577-z","volume":"18","author":"A Daryadel","year":"2019","unstructured":"Daryadel, A. et al. Elevated FGF23 and disordered renal mineral handling with reduced bone mineralization in chronically erythropoietin over-expressing Transgenic mice. Sci. Rep. 18 (9(1), 14989 (2019).","journal-title":"Sci. Rep."},{"issue":"4","key":"3031_CR47","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2478\/jomb-2019-0002","volume":"30","author":"M Bouksila","year":"2019","unstructured":"Bouksila, M. et al. Correlation of Fgf23 and Balp with bone mineral density in Hemodialysis patients. J. Med. Biochem. 30 (4), 418\u2013426 (2019).","journal-title":"J. Med. Biochem."},{"issue":"1","key":"3031_CR48","doi-asserted-by":"publisher","first-page":"107476","DOI":"10.1016\/j.jdiacomp.2019.107476","volume":"34","author":"AL Ribeiro","year":"2020","unstructured":"Ribeiro, A. L. et al. FGF23-klotho axis as predictive factors of fractures in type 2 diabetics with early chronic kidney disease. J. Diabetes Complications. 34 (1), 107476 (2020).","journal-title":"J. Diabetes Complications"},{"issue":"7","key":"3031_CR49","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/ki.2012.176","volume":"82","author":"M Wolf","year":"2012","unstructured":"Wolf, M. Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int. 82 (7), 737\u2013747 (2012).","journal-title":"Kidney Int."},{"key":"3031_CR50","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cca.2020.03.013","volume":"505","author":"MG Vervloet","year":"2020","unstructured":"Vervloet, M. G. FGF23 measurement in chronic kidney disease: what is it really reflecting? Clin. Chim. Acta. 505, 160\u2013166 (2020).","journal-title":"Clin. Chim. Acta"},{"issue":"13","key":"3031_CR51","doi-asserted-by":"publisher","first-page":"1046392","DOI":"10.3389\/fendo.2022.1046392","volume":"9","author":"TV Grigore","year":"2023","unstructured":"Grigore, T. V. et al. Fibroblast growth factor 23 is independently associated with renal magnesium handling in patients with chronic kidney disease. Front. Endocrinol. 9 (13), 1046392 (2023).","journal-title":"Front. Endocrinol."},{"issue":"1","key":"3031_CR52","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1684\/mrh.2013.0331","volume":"26","author":"H Matsuzaki","year":"2013","unstructured":"Matsuzaki, H., Kajita, Y. & Miwa, M. Magnesium deficiency increases serum fibroblast growth factor-23 levels in rats. Magnes Res. 26 (1), 18\u201323 (2013).","journal-title":"Magnes Res."},{"issue":"1","key":"3031_CR53","first-page":"65","volume":"35","author":"N Kaesler","year":"2020","unstructured":"Kaesler, N. et al. Magnesium but not nicotinamide prevents vascular calcification in experimental uraemia. Nephrol. Dial Transpl. 35 (1), 65\u201373 (2020).","journal-title":"Nephrol. Dial Transpl."},{"issue":"11","key":"3031_CR54","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/toxins11110647","volume":"6","author":"I Vogt","year":"2019","unstructured":"Vogt, I., Haffner, D. & Leifheit-Nestler, M. FGF23 and Phosphate-Cardiovascular toxins in CKD. Toxins (Basel). 6 (11), 647 (2019).","journal-title":"Toxins (Basel)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03031-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03031-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03031-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T19:02:32Z","timestamp":1748718152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03031-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3031"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-03031-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18486"}}